Key result
Extensive LV remodeling is linked to a ~33-point higher 3-year event rate despite viable myocardium.
Why the study?
Extensive left ventricular remodeling may prevent functional recovery after revascularization despite the presence of viable myocardium in ischemic cardiomyopathy patients.
Does extensive LV remodeling prevent LVEF improvement and worsen long-term prognosis after surgical revascularization in patients with ischemic cardiomyopathy despite the presence of viable myocardium?
Cohort (n=79)
Does extensive LV remodeling prevent LVEF improvement and worsen long-term prognosis after surgical revascularization in patients with ischemic cardiomyopathy despite the presence of viable myocardium?
Extensive left ventricular remodeling (indicated by large LV end-systolic volume) prevents LVEF recovery and is associated with worse long-term clinical outcomes after surgical revascularization, even when viable myocardium is present.
Answers are grounded in this paper and cite their sources.
LV remodeling may blunt LVEF recovery and raise events after revascularization despite viability; leaves open whether remodeling should modify viability-guided decisions.
Background— Extensive left ventricular (LV) remodeling may not allow functional recovery after revascularization, despite the presence of viable myocardium. Methods and Results— Seventy-nine consecutive patients with ischemic cardiomyopathy (left ventricle ejection fraction [LVEF] 29±7%) underwent surgical revascularization. Before revascularization, viability was assessed by metabolic imaging with F18-fluorodeoxyglucose and SPECT. LV volumes and LVEF were assessed by resting echocardiography. LVEF was re-assessed by echocardiography 8 to 12 months after revascularization. Three-year clinical follow-up (events: cardiac death, infarction, and hospitalization for heart failure) was also obtained. Forty-nine patients had substantial viability; 5 died before re-assessment of LVEF. Of the remaining 44 patients, 24 improved ≥5% in LVEF after revascularization, whereas 20 did not improve in LVEF. LV end-systolic volume was the only parameter that was significantly different between the groups (109±46 mL for the improvers versus 141±31 mL for the nonimprovers; P <0.05). The change in LVEF after revascularization was linearly related to the baseline LV end-systolic volume, with a higher LV end-systolic volume associated with a low likelihood of improvement in LVEF after revascularization. During the 3-year follow-up, the highest event-rate (67%) was observed in patients without viable myocardium with a large LV size, whereas the lowest event rate (5%) was observed in patients with viable myocardium and a small LV size. Intermediate event rates were observed in patients with viable myocardium and a large LV size (38%), and in patients without viable myocardium and a small LV size (24%). Conclusion— Extensive LV remodeling prohibits improvement in LVEF after revascularization and affects long-term prognosis negatively, despite the presence of viability.
No takes yet. Share an insight, caveat, or question.
Bax et al. (2004) conducted a cohort in Ischemic cardiomyopathy (n=79). Extensive left ventricular remodeling (large LV size) with viable myocardium vs. Small LV size with viable myocardium was evaluated on 3-year clinical events (cardiac death, infarction, and hospitalization for heart failure). Extensive LV remodeling with viable myocardium was associated with a 3-year event rate compared to small LV size, and prohibited LVEF improvement after revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: